Robert Casey actually said...

"It is astonishing that for a drug approaching 100 years old and that is serving millions of Americans that we do not see a proliferation of manufacturers but, rather, just three major manufacturers."

"The sensitivity to that out-of-pocket cost for the insulin-depending patient is extraordinarily important."

"I live in a state where the Governor signed legislation to expand Medicaid, thankfully. Seven hundred thousand people, more than 700,000, have affordable coverage because of that act."

"The horror of opioids in my State, as it is true I am sure of a number of States, it is very bad in urban areas and suburban areas."